笑气
笑气用途
1.超临界溶剂。单独或与氧气混合用作牙科、外科和妇产科的麻醉剂。也可用作防腐剂、制冷剂、助燃剂、烟雾喷射剂。食品工业作为发泡剂和食品的密封剂。电子工业用于二氧化硅的化学气相沉积等离子工艺。军火工业用作推进剂。还可用于气密性检查、原子吸收光谱的载体等。检漏剂、制冷剂,以及用作原子吸收光谱用的助燃剂。
2.本产品用作医用麻醉剂、制冷剂、助燃剂、防腐剂、烟雾喷射剂、标准气和平衡气等,也用于半导体制造中的乳化CVD工序及气相淀积氮化硅的氮源。还可作为原子吸收光谱的氧化气体。
3.用于电子工业中二氧化硅的化学气相淀积等离子工艺。
4.用作医药麻醉剂、防腐剂,以及用于气密性检查。
笑气名称
[ CAS 号 ]:
10024-97-2
[ 中文名 ]:
氧化亚氮
[ 英文名 ]:
nitrous oxide
[中文别名 ]:
[英文别名 ]:
- EINECS 233-032-0
- MFCD00011492
- NITROUS OXIDE
笑气物理化学性质
[ 密度 ]:
1.46 g/cm3
[ 沸点 ]:
−88 °C(lit.)
[ 熔点 ]:
−91 °C(lit.)
[ 分子式 ]:
N2O
[ 分子量 ]:
44.01280
[ 精确质量 ]:
44.00110
[ PSA ]:
54.46000
[ LogP ]:
0.06366
[ 外观性状 ]:
无色压缩液化气体
[ 蒸汽密度 ]:
1.53 (15 °C, vs air)
[ 蒸汽压 ]:
51.7 mm Hg ( 21 °C)
[ 折射率 ]:
1.469
[ 储存条件 ]:
库房通风低温干燥,与有机物、易燃气体分开存放
[ 稳定性 ]:
Oxidant, strongly supports combustion. May react violently with some materials. Thermal decomposition yields toxic products. Incompatible with aluminium, boron oxides, hydrazine, strong reducing agents.
[ 水溶解性 ]:
每100毫升水中的溶解克数: 0.112g/20℃
笑气MSDS
笑气毒性和生态
CHEMICAL IDENTIFICATION
- RTECS NUMBER :
- QX1350000
- CHEMICAL NAME :
- Nitrogen oxide
- CAS REGISTRY NUMBER :
- 10024-97-2
- LAST UPDATED :
- 199712
- DATA ITEMS CITED :
- 41
- MOLECULAR FORMULA :
- N2-O
- MOLECULAR WEIGHT :
- 44.02
- WISWESSER LINE NOTATION :
- N2 O
HEALTH HAZARD DATA
ACUTE TOXICITY DATA
- TYPE OF TEST :
- TCLo - Lowest published toxic concentration
- ROUTE OF EXPOSURE :
- Inhalation
- SPECIES OBSERVED :
- Human
- DOSE/DURATION :
- 24 mg/kg/2H
- TOXIC EFFECTS :
- Behavioral - general anesthetic Cardiac - pulse rate Nutritional and Gross Metabolic - body temperature decrease
- TYPE OF TEST :
- TCLo - Lowest published toxic concentration
- ROUTE OF EXPOSURE :
- Inhalation
- SPECIES OBSERVED :
- Rodent - mouse
- DOSE/DURATION :
- 50 ppm/6H/13W-I
- TOXIC EFFECTS :
- Liver - changes in liver weight Blood - changes in leukocyte (WBC) count
- TYPE OF TEST :
- TCLo - Lowest published toxic concentration
- ROUTE OF EXPOSURE :
- Inhalation
- DOSE :
- 5 pph/4H
- SEX/DURATION :
- female 6-15 day(s) after conception
- TOXIC EFFECTS :
- Reproductive - Effects on Newborn - behavioral
- TYPE OF TEST :
- TCLo - Lowest published toxic concentration
- ROUTE OF EXPOSURE :
- Inhalation
- DOSE :
- 20 pph/8H
- SEX/DURATION :
- male 28 day(s) pre-mating
- TOXIC EFFECTS :
- Reproductive - Paternal Effects - testes, epididymis, sperm duct
- TYPE OF TEST :
- TCLo - Lowest published toxic concentration
- ROUTE OF EXPOSURE :
- Inhalation
- DOSE :
- 50 pph/24H
- SEX/DURATION :
- female 8-11 day(s) after conception
- TOXIC EFFECTS :
- Reproductive - Specific Developmental Abnormalities - Central Nervous System Reproductive - Specific Developmental Abnormalities - cardiovascular (circulatory) system Reproductive - Specific Developmental Abnormalities - urogenital system
- TYPE OF TEST :
- TCLo - Lowest published toxic concentration
- ROUTE OF EXPOSURE :
- Inhalation
- DOSE :
- 50 ppm/6H
- SEX/DURATION :
- male 30 day(s) pre-mating
- TOXIC EFFECTS :
- Reproductive - Effects on Newborn - live birth index (measured after birth) Reproductive - Effects on Newborn - growth statistics (e.g.%, reduced weight gain)
- TYPE OF TEST :
- TCLo - Lowest published toxic concentration
- ROUTE OF EXPOSURE :
- Inhalation
- DOSE :
- 1 pph/8H
- SEX/DURATION :
- female 1-21 day(s) after conception
- TOXIC EFFECTS :
- Reproductive - Effects on Embryo or Fetus - extra-embryonic structures (e.g., placenta, umbilical cord) Reproductive - Effects on Embryo or Fetus - fetal death
- TYPE OF TEST :
- TCLo - Lowest published toxic concentration
- ROUTE OF EXPOSURE :
- Inhalation
- DOSE :
- 50 pph/4H
- SEX/DURATION :
- female 14 day(s) after conception
- TOXIC EFFECTS :
- Reproductive - Effects on Newborn - biochemical and metabolic
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Subcutaneous
- DOSE :
- 3 gm/kg
- SEX/DURATION :
- female 8 day(s) after conception
- TOXIC EFFECTS :
- Reproductive - Fertility - post-implantation mortality (e.g. dead and/or resorbed implants per total number of implants) Reproductive - Effects on Embryo or Fetus - other effects to embryo Reproductive - Specific Developmental Abnormalities - musculoskeletal system
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Subcutaneous
- DOSE :
- 3 gm/kg
- SEX/DURATION :
- female 8 day(s) after conception
- TOXIC EFFECTS :
- Reproductive - Specific Developmental Abnormalities - cardiovascular (circulatory) system
- TYPE OF TEST :
- TCLo - Lowest published toxic concentration
- ROUTE OF EXPOSURE :
- Inhalation
- DOSE :
- 75 pph/6H
- SEX/DURATION :
- female 14 day(s) after conception
- TOXIC EFFECTS :
- Reproductive - Effects on Embryo or Fetus - cytological changes (including somatic cell genetic material)
- TYPE OF TEST :
- TCLo - Lowest published toxic concentration
- ROUTE OF EXPOSURE :
- Inhalation
- DOSE :
- 5000 ppm/4H
- SEX/DURATION :
- female 14 day(s) after conception
- TOXIC EFFECTS :
- Reproductive - Effects on Newborn - behavioral
- TYPE OF TEST :
- TCLo - Lowest published toxic concentration
- ROUTE OF EXPOSURE :
- Inhalation
- DOSE :
- 90 pph/24H
- SEX/DURATION :
- female 10 day(s) after conception
- TOXIC EFFECTS :
- Reproductive - Fertility - post-implantation mortality (e.g. dead and/or resorbed implants per total number of implants)
- TYPE OF TEST :
- TCLo - Lowest published toxic concentration
- ROUTE OF EXPOSURE :
- Inhalation
- DOSE :
- 95 pph/24H
- SEX/DURATION :
- female 7 day(s) after conception
- TOXIC EFFECTS :
- Reproductive - Effects on Embryo or Fetus - fetotoxicity (except death, e.g., stunted fetus)
- TYPE OF TEST :
- Sex chromosome loss and nondisjunction
- TYPE OF TEST :
- DNA inhibition
- TYPE OF TEST :
- DNA inhibition
MUTATION DATA
- TEST SYSTEM :
- Rodent - rat
- REFERENCE :
- TCMUD8 Teratogenesis, Carcinogenesis, and Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1980- Volume(issue)/page/year: 8,107,1988 *** REVIEWS *** ACGIH TLV-Not classifiable as a human carcinogen DTLVS* The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 Volume(issue)/page/year: TLV/BEI,1997 ACGIH TLV-TWA 90 mg/m3 (50 ppm) DTLVS* The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 Volume(issue)/page/year: TLV/BEI,1997 IARC Cancer Review:Animal Inadequate Evidence IMSUDL IARC Monographs, Supplement. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.1- 1979- Volume(issue)/page/year: 7,93,1987 TOXICOLOGY REVIEW CLPTAT Clinical Pharmacology and Therapeutics (St. Louis). (C.V. Mosby Co., 11830 Westline Industrial Dr., St. Louis, MO 63146) V.1- 1960- Volume(issue)/page/year: 8,91,1967 TOXICOLOGY REVIEW AACRAT Anesthesia and Analgesia (New York). (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.36- 1957- Volume(issue)/page/year: 57,328,1978 TOXICOLOGY REVIEW XPHBAO U.S. Public Health Service, Public Health Bulletin. (Washington, DC) Volume(issue)/page/year: 272,1,1941 *** U.S. STANDARDS AND REGULATIONS *** MSHA STANDARD:ASPHYXIANTS/GASES DTLWS* "Documentation of the Threshold Limit Values for Substances in Workroom Air," Supplements. For publisher information, see 85INA8. Volume(issue)/page/year: 3,25,1973 OSHA PEL (Construc): simple asphyxiant-inert gases and vapors CFRGBR Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) Volume(issue)/page/year: 29,1926.55,1994 OSHA PEL (Shipyard):Simple asphyxiant - inert gas and vapor CFRGBR Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) Volume(issue)/page/year: 29,1915.1000,1993 *** OCCUPATIONAL EXPOSURE LIMITS *** OEL-DENMARK:TWA 100 ppm (180 mg/m3) JAN 1993 OEL-SWEDEN:TWA 100 ppm (180 mg/m3);STEL 500 ppm (900 mg/m3) JAN 1993 OEL IN BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGIH TLV *** NIOSH STANDARDS DEVELOPMENT AND SURVEILLANCE DATA *** NIOSH RECOMMENDED EXPOSURE LEVEL (REL) : NIOSH REL TO NITROUS OXIDE-air:TWA 25 ppm for duration of exposure REFERENCE : NIOSH* National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. Volume(issue)/page/year: DHHS #92-100,1992 NIOSH OCCUPATIONAL EXPOSURE SURVEY DATA : NOHS - National Occupational Hazard Survey (1974) NOHS Hazard Code - 51118 No. of Facilities: 5599 (estimated) No. of Industries: 45 No. of Occupations: 36 No. of Employees: 113333 (estimated) NOES - National Occupational Exposure Survey (1983) NOES Hazard Code - 51118 No. of Facilities: 5145 (estimated) No. of Industries: 25 No. of Occupations: 34 No. of Employees: 112585 (estimated) No. of Female Employees: 74465 (estimated)
笑气安全信息
[ 危害码 (欧洲) ]:
O
[ 风险声明 (欧洲) ]:
R8
[ 安全声明 (欧洲) ]:
S38
[ 危险品运输编码 ]:
UN 1070 2.2
[ WGK德国 ]:
1
[ RTECS号 ]:
QX1350000
[ 危险类别 ]:
2.2
笑气上下游产品
笑气上游产品
笑气下游产品
笑气制备
1.热解法 加热硝酸铵或加热无水硝酸钠与硫酸铵的混合物,生成的气体经精制、压缩、冷却、干燥、液化等工序,制得一氧化二氮成品。
2.催化氧化法 氨与空气在催化剂存在条件下发生催化氧化反应,生成的气体经精制得到粗一氧化二氮气体。该气体经压缩、高压水洗,再经压缩、干燥、液化工序,制得液体一氧化二氮产品。
3.市场上可以买到麻醉用一氧化二氮。实验室常用热分解NH4NO3制得。将纯硝酸铵放在烘箱中烘至160~170℃,令其完全脱水后,放入干燥器中凝固。将它研细装入带有支管的圆底烧瓶中。烧瓶颈上缠绕加热线圈,不让分解反应中生成的水冷凝回到熔融的反应物里。烧瓶支管接上一冰冷阱,使生成的水大部分冷凝下来。将烧瓶放在铁丝网上小心地加热,反应在170℃开始,温度不可超过250℃,以防止分解为N2和NO的反应发生。因为这是放热反应,应避免加热过急和反应物的量过多,否则有可能变成爆炸反应。生成的N2O用50%的KOH溶液洗涤。若有必要,微量的氧气可用连二亚硫酸盐的碱性溶液除去。
4.以纯度为95%~97%的一氧化二氮为原料,经常温吸附和低温下数次间歇抽空,可制得纯度达99.998%的高纯一氧化二氮产品。采用硝酸铵加热分解法可制取粗一氧化二氮,易分离和净化,再经提纯可得到高纯产品。反应式如下。
相关药品:
推荐生产厂家/供应商:
相关化合物
【笑气】化源网提供笑气CAS号10024-97-2,笑气MSDS及其说明、性质、英文名、生产厂家、作用/用途、分子量、密度、沸点、熔点、结构式等。CAS号查询笑气上化源网,专业又轻松。>>电脑版:笑气
标题:笑气_MSDS_用途_密度_笑气CAS号【10024-97-2】_化源网 地址:https://www.chemsrc.com/amp/cas/10024-97-2_951993.html